Torrent Pharmaceuticals Ltd.
₹4,220.2
-45.4 (-1.1%)
TORNTPHARM Share Price
As on March 30, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 1,42,831 Cr
P/E Ratio74.73
Dividend Yield0.15 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open4,222.9
High4,261.6
NSE SymbolTORNTPHARM
Close4,220.2
Low4,188.2
BSE Symbol500420
Previous Years High/Low
1 Year High4,482.9
3 Year High4,482.9
5 Year High4,482.9
1 Year Low3,101.6
3 Year Low1,524.35
5 Year Low1,237.75
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 4,250.76 | Bearish |
| 10-DMA | 4,259.62 | Bearish |
| 20-DMA | 4,318.98 | Bearish |
| 50-DMA | 4,184.46 | Bullish |
| 100-DMA | 3,993.01 | Bullish |
| 200-DMA | 3,754.24 | Bullish |
Historical Performance
1 Year
30.7%
3 Years
174.1%
5 Years
233.7%
10 Years
524.8%
Shareholding Pattern
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
| Net Sales | 1,15,161 | 1,07,278 | 96,202 | 85,080 | 80,046 |
| Total Expenditure | 78,117 | 73,642 | 67,962 | 60,768 | 55,245 |
| Other Income | 399 | 620 | 632 | 1,966 | 569 |
| Operating Profit | 37,443 | 34,256 | 28,872 | 26,278 | 25,370 |
| Interest | 2,523 | 3,536 | 3,334 | 2,551 | 3,529 |
| Depreciation | 7,949 | 8,083 | 7,066 | 6,622 | 6,578 |
| Profit Before Tax | 26,728 | 23,521 | 18,472 | 12,259 | 15,263 |
| Consolidated Net Profit | 19,112 | 16,564 | 12,452 | 7,772 | 12,519 |
| Adjusted EPS | 56 | 49 | 37 | 23 | 37 |
Compounded Sales Growth
10 Years:19.9
5 Years:7.7
3 Years:6.2
TTM:1.4
Compounded Profit Growth
10 Years:20.5
5 Years:13.3
3 Years:19.7
TTM:2.9
Stock Price CAGR
10 Years:20
5 Years:27.1
3 Years:40
TTM:32.6
Return on Equity
10 Years:51.2
5 Years:37
3 Years:36.8
last year:56.5
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
| Share Capital | 1,692 | 1,692 | 1,692 | 846 | 846 |
| Total Reserves | 74,215 | 66,869 | 60,288 | 58,683 | 57,525 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 20,877 | 22,241 | 28,228 | 22,381 | 29,242 |
| Other Current Liabilities | 11,435 | 11,302 | 15,784 | 13,651 | 16,354 |
| Short Term Borrowings | 12,500 | 16,377 | 17,651 | 9,230 | 7,044 |
| Total Liabilities | 1,43,956 | 1,45,055 | 1,44,682 | 1,26,062 | 1,36,530 |
| Capital Work in Progress | 3,673 | 2,808 | 6,882 | 5,443 | 7,439 |
| Long Term Loans & Advances | 2,943 | 3,493 | 1,810 | 1,666 | 968 |
| Currents Investments | 1,122 | 1,410 | 1,561 | 1,840 | 1,391 |
| Short Term Loans and Advances | 1,996 | 1,800 | 1,658 | 1,512 | 634 |
| Total Current Assets | 56,226 | 56,115 | 53,137 | 51,650 | 55,215 |
| Total Assets | 1,43,956 | 1,45,055 | 1,44,682 | 1,26,062 | 1,36,530 |
| Adjusted Book Value | 224 | 203 | 183 | 176 | 172 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 74.73, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a strong 3-year price CAGR of 39.8%, indicating sustained price appreciation.
- The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹37443 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹115161 million, indicating a large and established business.
Investment Calculator
Investment Amount:
₹Investment Amount: ₹ 1000000
Current Value: ₹ 1325481.3
No. of Shares: 314 (Approx)
Performance:32.5%
P/L: ₹325481.3
NIFTY Performance: -3.6%
1 day Top Gainers
| Symbol | Change% |
|---|---|
| IRB | 22.14(8%) |
| AIAENG | 3636.6(5%) |
| NATIONALUM | 386.1(4%) |
| SAIL | 151.42(3%) |
| BAYERCROP | 4645.6(3%) |
1 Day Top Losers
| Symbol | Change% |
|---|---|
| AIIL | 429.85(-12%) |
| DBREALTY | 83.97(-9%) |
| HINDCOPPER | 453.5(-8%) |
| ANANTRAJ | 405.7(-7%) |
| HAPPSTMNDS | 361.05(-7%) |
| WELSPUNLIV | 108.32(-7%) |
| APARINDS | 9881(-7%) |
| FIRSTCRY | 208.34(-7%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
